These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 31503152)

  • 1. Relationship Between Etonogestrel Concentrations and Bleeding Patterns in Contraceptive Implant Users.
    Lazorwitz A; Aquilante CL; Dindinger E; Harrison M; Sheeder J; Teal S
    Obstet Gynecol; 2019 Oct; 134(4):807-813. PubMed ID: 31503152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An exploratory study on the association of lifestyle factors with serum etonogestrel concentrations among contraceptive implant users.
    Lazorwitz A; Sheeder J; Teal S
    Eur J Contracept Reprod Health Care; 2021 Aug; 26(4):323-325. PubMed ID: 33596152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applicability of ancestral genotyping in pharmacogenomic research with hormonal contraception.
    Lazorwitz A; Aquilante CL; Shortt JA; Sheeder J; Teal S; Gignoux CR
    Clin Transl Sci; 2021 Sep; 14(5):1713-1718. PubMed ID: 33650294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between patient characteristics and serum etonogestrel concentrations in contraceptive implant users.
    Lazorwitz A; Aquilante CL; Sheeder J; Guiahi M; Teal S
    Contraception; 2019 Jul; 100(1):37-41. PubMed ID: 30980827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Etonogestrel implant use in women primarily choosing a combined oral contraceptive pill: A proof-of-concept trial.
    Chen MJ; Hsia JK; Creinin MD
    Contraception; 2018 Jun; 97(6):533-537. PubMed ID: 29496473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of immediate postpartum compared to delayed postpartum and interval etonogestrel contraceptive implant insertion on removal rates for bleeding.
    Ireland LD; Goyal V; Raker CA; Murray A; Allen RH
    Contraception; 2014 Sep; 90(3):253-8. PubMed ID: 24973904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged use of the etonogestrel implant and levonorgestrel intrauterine device: 2 years beyond Food and Drug Administration-approved duration.
    McNicholas C; Swor E; Wan L; Peipert JF
    Am J Obstet Gynecol; 2017 Jun; 216(6):586.e1-586.e6. PubMed ID: 28147241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of carbamazepine on etonogestrel concentrations in contraceptive implant users.
    Lazorwitz A; Davis A; Swartz M; Guiahi M
    Contraception; 2017 Jun; 95(6):571-577. PubMed ID: 28288788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-Term Treatment of Bothersome Bleeding for Etonogestrel Implant Users Using a 14-Day Oral Contraceptive Pill Regimen: A Randomized Controlled Trial.
    Guiahi M; McBride M; Sheeder J; Teal S
    Obstet Gynecol; 2015 Sep; 126(3):508-513. PubMed ID: 26181091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized trial of double vs single-dose etonogestrel implant to overcome the interaction with efavirenz-based antiretroviral therapy.
    Chappell CA; Lamorde M; Nakalema S; Kyohairwe I; Byakika-Kibwika P; Meyn LA; Pham MM; Scarsi KK
    Am J Obstet Gynecol; 2024 Aug; 231(2):242.e1-242.e9. PubMed ID: 38458408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pilot study of a novel, alternative subdermal scapular insertion site for the etonogestrel contraceptive implant.
    Clure C; Sheeder J; Lazorwitz A
    Contraception; 2024 Jul; 135():110442. PubMed ID: 38552822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amenorrhea in adolescents using the etonogestrel contraceptive implant.
    Tsevat D; Mercier R; Bernheimer C; Lin S; Schwartz B
    Contraception; 2024 May; 133():110413. PubMed ID: 38401772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined oral contraceptive treatment for bleeding complaints with the etonogestrel contraceptive implant: a randomised controlled trial.
    Hou MY; McNicholas C; Creinin MD
    Eur J Contracept Reprod Health Care; 2016 Oct; 21(5):361-6. PubMed ID: 27419258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can initial vaginal bleeding patterns in etonogestrel implant users predict subsequent bleeding in the first 2 years of use?
    Mansour D; Fraser IS; Edelman A; Vieira CS; Kaunitz AM; Korver T; Pong A; Lin J; Shah AK; Fox M; Rekers H; Creinin MD
    Contraception; 2019 Oct; 100(4):264-268. PubMed ID: 31176688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Unfavorable Bleeding Patterns in Contraceptive Implant Users: A Randomized Controlled Trial.
    Edelman AB; Kaneshiro B; Simmons KB; Hauschildt JL; Bond K; Boniface ER; Jensen JT
    Obstet Gynecol; 2020 Aug; 136(2):323-332. PubMed ID: 32649493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Timing of postpartum etonogestrel-releasing implant insertion and bleeding patterns, weight change, 12-month continuation and satisfaction rates: a randomized controlled trial.
    Vieira CS; de Nadai MN; de Melo Pereira do Carmo LS; Braga GC; Infante BF; Stifani BM; Ferriani RA; Quintana SM
    Contraception; 2019 Oct; 100(4):258-263. PubMed ID: 31145885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of Genetic Variants on Steady-State Etonogestrel Concentrations Among Contraceptive Implant Users.
    Lazorwitz A; Aquilante CL; Oreschak K; Sheeder J; Guiahi M; Teal S
    Obstet Gynecol; 2019 Apr; 133(4):783-794. PubMed ID: 30870275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical experience and acceptability of the etonogestrel subdermal contraceptive implant.
    Flores JB; Balderas ML; Bonilla MC; Vázquez-Estrada L
    Int J Gynaecol Obstet; 2005 Sep; 90(3):228-33. PubMed ID: 16043175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of plasma etonogestrel concentrations sampled from the contralateral-to-implant and ipsilateral-to-implant arms of contraceptive implant users.
    Gertz AM; Bishop IJ; Simon B; Lechiile K; Badubi O; Mussa A; Westhoff CL; Morroni C
    Contraception; 2020 Dec; 102(6):403-405. PubMed ID: 32858051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bleeding patterns of HIV-infected women using an etonogestrel-releasing contraceptive implant and efavirenz-based or lopinavir/ritonavir-based antiretroviral therapy.
    Ragazini CS; Bahamondes MV; Prandini TR; Brito MB; Amaral E; Bahamondes L; Duarte G; Quintana SM; Ferriani RA; Vieira CS
    Eur J Contracept Reprod Health Care; 2016 Aug; 21(4):285-9. PubMed ID: 27227739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.